AVITA Medical, Inc. 8-K

What Happened

• AVITA Medical, Inc. (RCEL) filed a Form 8-K on February 12, 2026 to announce its financial results for the fourth quarter and full year ended December 31, 2025. The company furnished a press release with those results as Exhibit 99.1 to the filing. The report was signed by David O’Toole, Chief Financial Officer.

Key Details

• Filing date: February 12, 2026.
• Reporting periods covered: Q4 2025 and full year ended December 31, 2025.
• Disclosure method: press release furnished as Exhibit 99.1 (and an Inline XBRL cover page, Exhibit 104).
• Form 8-K item: 2.02 (Results of Operations and Financial Condition).

Why It Matters

• This 8-K signals AVITA has publicly released its latest quarterly and annual earnings information; those results can affect revenue, profitability metrics, guidance, and the stock price.
• Retail investors should read the furnished press release (Exhibit 99.1) and any related financial statements or XBRL data to see the specific revenue, earnings, cash flow, and management commentary for Q4 and FY2025.